UBS Group’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

UBS Group’s Portfolio ARYE Stock Details ARYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-449	Closed	-$4.65K	–	10339
2023 Q2	$4.65K	Buy	+449	New	+$4.62K	﹤0.01%	7511
2023 Q1	–	Sell	-1,649	Closed	-$16.6K	–	11105
2022 Q4	$16.6K	Buy	1,649 +200	+14%	+$1.99K	﹤0.01%	7888
2022 Q3	$14K	Buy	1,449 +300	+26%	+$2.93K	﹤0.01%	7969
2022 Q2	$11K	Buy	1,149 +99	+9%	+$961	﹤0.01%	7901
2022 Q1	$10K	Hold	1,050	–	–	﹤0.01%	8477
2021 Q4	$10K	Hold	1,050	–	–	﹤0.01%	8832
2021 Q3	$10K	Buy	+1,050	New	+$10.4K	﹤0.01%	8040

UBS Group's ARYE Position: Q3 2023 in Review

UBS Group sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q3 2023, closing a stake of 449 shares — an estimated $4.65K sold.

UBS Group first reported a position in ARYE in Q3 2021 and held it in 7 quarters. The position peaked at $16.6K in Q4 2022. 0 funds tracked by Wall St. Rank hold ARYE as of Q3 2023.

UBS Group reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
UBS Group sold 449 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q3 2023, an estimated $4.65K.
UBS Group first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 7 quarters.
UBS Group's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $16.6K in Q4 2022.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.